Allergy Treatment Market to Grow with a CAGR of 7.76% through 2030
Increasing
prevalence of various allergies is expected to drive the growth of global
allergy treatment market in the forecast period, 2026-2030.
According to
TechSci Research report, “Allergy
Treatment Market
- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2030”, the Global Allergy Treatment Market was valued at USD 23.14 billion in 2024 and is expected to reach USD 36.24 billion by 2030 with a CAGR of 7.76% during the forecast period. This can be ascribed to the increasing
burden of different types of allergies. Additionally, increasing investments by
manufacturers for the development of novel allergic treatments is expected to
support the market growth during the forecast period. Besides, growing
importance for self-medication has further increased the demand for different allergy
treatments. However, increasing popularity of
biosimilars can slow down the growth of global allergy treatment markets. Also,
the side effects caused due to different anti-allergic treatments can further
hamper the growth of global allergy treatment market during the forecast
period.
Browse over XX market data Figures spread through XX Pages and an in-depth
TOC on "Global Allergy Treatment Market"
The global allergy treatment market is segmented into type, treatment, route of
administration, distribution channel, regional distribution and company.
Based on Treatment, Immunotherapy is the fastest-growing category in the global allergy treatment market. Unlike anti-allergy medications, which provide temporary relief from symptoms, immunotherapy works on the root cause of allergic reactions by gradually desensitizing the immune system to specific allergens. This disease-modifying approach is becoming increasingly popular worldwide as both doctors and patients recognize its long-term benefits. Governments and health organizations are also supporting the wider use of immunotherapy. For example, in Europe and North America, clinical guidelines now recommend subcutaneous (injections) and sublingual (tablets or drops) immunotherapy for patients with allergic rhinitis and asthma who do not respond well to medications. Clinical studies funded by national health agencies have shown that immunotherapy can reduce symptoms, lower the need for emergency care, and improve overall quality of life.
Based on Region, Asia Pacific is emerging as the fastest-growing region in the global allergy treatment market. This rapid growth is largely driven by the rising prevalence of allergic conditions, increasing urbanization, and environmental changes in countries such as China, India, Japan, and South Korea. According to government health statistics, asthma and allergic rhinitis have been steadily increasing in many parts of Asia, with urban populations particularly vulnerable due to higher levels of air pollution, industrial emissions, and changing climate patterns that prolong pollen seasons. Another factor fueling growth is the region’s large and diverse population base. With billions of people living in Asia Pacific, even modest increases in allergy prevalence translate into significant numbers of patients requiring diagnosis and treatment. Growing awareness about allergies, coupled with improved healthcare infrastructure in emerging economies, has led to higher diagnosis rates and greater demand for both over the counter and prescription treatments.
Major
companies operating in Global Allergy Treatment Market are:
- Johnson & Johnson
- Sanofi SA
- GlaxoSmithKline plc.
- F. Hoffmann-La Roche AG
- Leti Pharma GmbH
- AbbVie Inc.
- Alembic Pharmaceuticals Limited
- Bausch Health Companies Inc.
- Novartis AG
- ALK-Abello AS
Download Free Sample Report
Customers can also request for 10% free
customization on this report.
“The North America is expected to register the highest growth in the
global allergy treatment market on account of growing prevalence of different
forms of allergies in the region especially food allergies and asthma.
Additionally, there are numerous drugs under development in the region,
especially in the United States for the treatment of different allergies.
Besides, presence of key market players developing different allergy treatments
in the region is further expected to create lucrative opportunities for the
market growth” said Mr. Karan Chechi, Research Director of TechSci Research,
a research based global management consulting firm.
“Allergy Treatment Market - Global Industry Size, Share, Trends,
Opportunity, and Forecast, Segmented By Type (Eye Allergy, Food Allergy, Skin
Allergy, Asthma, Rhinitis, Others), By Treatment (Anti-Allergy Medications v/s
Immunotherapy), By Route of administration (Oral, Inhalers, Intranasal, Others), By Distribution
channel (Hospital
Pharmacies, Retail Pharmacies, Online Pharmacies), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of global allergy treatment market
and provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in global allergy treatment market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com